5-Year Clinical Data on Cartiva Synthetic Cartilage Implant
Five-year results from a clinical trial of the Cartiva Synthetic Cartilage Implant in the treatment of great toe arthritis demonstrated pain relief and functional...
Mar 13, 2017,
5-Year Clinical Data on Cartiva Synthetic Cartilage Implant
Extremity Medical Product Launch Plans for 2017
Extremity Medical’s 2017 product launch plans include systems for Charcot fixation, total wrist arthroplasty, MTP fusion and Jones fracture....
Mar 13, 2017, Julie Vetalice
Paragon 28 Launches the Gorilla Calc Fracture Plating System
Paragon 28 launched the Gorilla® Calc Fracture Plating System for the treatment of calcaneal fractures....
Mar 13, 2017, Julie Vetalice
DJO Global Launches AltiVate Anatomic Shoulder
DJO Global launched the AltiVate™ Anatomic Shoulder, featuring P2, a proprietary “porous porous” coating designed to provide superior bone ingrowth....
Mar 13, 2017, Julie Vetalice
Broader FDA Clearance for Spineology Elite Expandable Interbody Fusion System
Spineology received expanded FDA 510(k) clearance of the Elite Expandable Interbody Fusion system, to include a narrower 10mm version of the device and...
Mar 13, 2017, Julie Vetalice
Ethicon, DePuy Synthes Launch Wound Closure Kits for Orthopaedic Surgery
Ethicon and DePuy Synthes commenced U.S. launch of wound closure kits customized for orthopaedic surgery, including STRATAFIX™ Knotless Tissue Control...
Mar 13, 2017, Julie Vetalice
Consensus Orthopedics Launches Orthopaedic Post-Surgical Wearable
Consensus Orthopedics launched TracPatch™, a wearable device for real-time, continuous post-surgical remote patient monitoring following total joint replacement....
Mar 09, 2017, Julie Vetalice
Second Patent for TheraCell Demineralized Bone Fiber Technology
TheraCell was awarded U.S. Patent Number 9,572,912, “Demineralized Bone Fibers having Controlled Geometry and Shapes and Methods Thereof,” its second...
Mar 09, 2017, Julie Vetalice
Positive Interim Data from Trial for BonyPid Antibiotic Eluting Bone Substitute
Interim results from study of BonyPid®-1000 bone substitute in the treatment of open tibial fractures indicate that the product met performance and...
Mar 09, 2017, Julie Vetalice
Recruitment Status for ALLOB Delayed-Union Study
Bone Therapeutics completed recruitment of 16 patients in the Phase I/IIA delayed-union fracture study of ALLOB® allogeneic cell therapy product....
Mar 09, 2017, Julie Vetalice
Loading new posts...
No more posts
